Finally, ex vivo treatment with nPKC-θi2 increased the expression of TNF-α and IFN-γ in CD8+ T cells from responder and resistant patients with advanced melanoma, consistent with our previous work showing that PKC-θ inhibition regulates the expression of these cytokines in human memory CD4+ T cells [5]. This evidence concerns the gene PRRT2 and melanoma.